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Background: There is a paucity of information on the heterogeneity of vascular smooth 
muscles in their responses to agonists following exposure to varying extracellular magnesium, 
[Mg2+]0. The present study was designed to examine, comparatively, the influence of variations 
in [Mg2+]0 on vascular smooth muscles of rabbit aortic, carotid and femoral arteries. Methods: 
Contractile responses induced by Phenylephrine (PE), Histamine (HIST) and 5-
HydroxylTryptamine (5-HT) were examined on 2mm ring segments of the arteries which were 
suspended in 20 ml organ baths containing physiological salt solution (PSS), for measurement 
of isometric contractions, at 370C and pH 7.4. The medium was bubbled with 95% O2, 5% 
CO2, and rings were given an initial load of 2g. Cumulative concentration responses to the 
agonists were studied in normal PSS (control) and following 30 minutes exposure to Mg2+-free 
or high-Mg2+ (4.8mM) PSS. Contractile responses were expressed as percentage of 80 mM K+ 
contractions in normal PSS.  Results: Maximal contractions (Emax) induced by PE, HIST and 
5-HT compared with high K+ contraction in the various preparations were differentially altered 
(p<0.05) following exposure to varying [Mg2+]o. Conclusion: Based on the sensitivity (EC30) 
and  potency (EC50) values for the dose-response curves of the agonists, we report that vascular 
smooth muscles of rabbit aortic, carotid and femoral arteries demonstrate considerable 




Assessment of reactivity in vascular smooth muscle of 
blood vessels from different anatomical sites is 
particularly important in understanding the mechanisms 
of regional blood flow  regulation and  cardiovascular 
function in health and disease states. Considerable 
heterogeneity has been reported to exist in the 
responses of vascular smooth muscles to various 
vasoactive agents (Daemen and De Mey, 1995). 
Experimental, clinical and epidemiological studies have 
shown that changes in magnesium concentration affect 
blood flow, vascular reactivity, and blood pressure 
(Pascal et al., 1997;  Ebeigbe and Aloamaka,1986;  
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Saris et al., 2000; Touyz, 2008; Goytain and Quamme, 
2008)).  Low or high [Mg2+]o have been reported to 
enhance or attenuate (respectively), contractile 
response to agonists in different vascular beds (Altura 
and Altura 1978a; Altura et al., 1987) however, there is 
a paucity of information on the comparative effects of 
altered [Mg2+]o responses to agonists in different 
vascular preparations. The goal of the present study 
was to examines the effects of variations in [Mg2+]o on 
contractile responses induced by phenylephrine (PE), 
histamine (HIST) and 5-hydroxytryptamine (5-HT) on 
vascular smooth muscle of rabbit aorta, carotid and 
femoral arteries. 
 
MATERIALS AND METHODS 
Tissue preparation and Protocol: 
Arterial segments of the aorta, carotid and femoral 
arteries were obtained from adult New Zealand rabbits 
which were sacrificed by stunning and bleeding and 
placed in physiological salt solution (PSS) of the 
following composition (mM):  NaCl 119, KCl 4.7, 
NaHCO3 24.9, NaH2PO4 1.2, MgSO4 1.2, CaCl2 1.6, 
glucose 11.5. The arteries were cleaned of adhering 
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connective tissues and cut into 2-3mm rings. The rings 
were suspended between 2 L-shaped wire loops in 20 
ml organ baths containing PSS. The upper loop was 
attached to a Grass Model FT03 force transducer 
connected to a Grass Model 7P polygraph (Grass 
Instruments Co., Quincy, MA, USA) while the lower 
loop was fixed to the base of the organ bath.  An initial 
load of 2g was applied. The PSS was bubbled 
throughout with 95% O2 - 5% CO2 gas mixture with the 
pH and temperature maintained at 7.4 and 37oC 
respectively.  An equilibration period of 90 minutes 
was allowed; following this, aortic rings were 
stimulated twice with 8 x 10-2M K+ PSS, at 20-minute 
interval. The average of these contractions represented 
the maximum (100%) agonist/KCl which subsequent 
contractions to phenylephrine or histamine were 
evaluated.  
 
Concentration-response to agonists: 
Cumulative concentration-response tests (1x10-9 to 2.5 
x10-4)  to each of the  3 agonists (PE, HIST and 5-HT) 
were examined in normal PSS (control) (n = 8); as well 
as following 30 minutes exposure to Mg2+-free or high-




The following drugs and chemical reagents were used: 
Phenylephrine hydrochloride (Sigma USA), histamine 
hydrochloride (Merck AG, Germany) and 5-
Hydroxytryptamine creatinine sulphate (Sigma USA); 
and prepared fresh by dissolving in distilled water. 
 
Statistical Analysis 
Data are presented as Means ± SEM (standard error of 
means); n represents the number of rabbits from which 
arterial rings were obtained. EC50 (concentrations 
producing 50% maximal response) were determined 
graphically. Comparison of the means was effected 
using the Student’s t-test, ANOVA and  Microcal 
origin 8.0 statistical package. P - Values less than 0.05 
(P<0.05) were considered statistically significant for 
two independent variables (test and control).  
 
RESULTS 
 (Mg2+)o and dose-response to agonists 
Exposure of arterial tissues to varying (Mg2+)o: 
Exposure of arterial rings to Mg2+ -free or high-Mg2+ 
PSS resulted in enhanced or attenuated contractions 
induced by the 3 agonists (PE, HIST and 5-HT) as 
shown in Figs 1-3. 
 
 
Fig.1. Dose response to agonists flowing exposure to varying (Mg2+)o PSS in aortic rings; n = 8. (Mg2+)o  exposure shifted the 
curves left-ward and enhanced maximal contractions whereas high-Mg2+ (4.8mM) PSS resulted in a right-ward shift and 






Fig.2. Dose response to agonists flowing exposure to varying (Mg2+)o PSS in carotid artery rings; n = 8. (Mg2+)o  exposure 
shifted the curves left-ward and enhanced maximal contractions whereas high-Mg2+ (4.8mM) PSS resulted in a right-ward shift 
and attenuated maximal contractions. Values are means ± SEM 
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Fig.3. Dose response to agonists (PE, HIST, & 5-HT) flowing exposure to varying (Mg2+)o PSS in femoral artery rings; n = 8. 
(Mg2+)o  exposure shifted the curves left-ward and enhanced maximal contractions whereas high-Mg2+ (4.8mM) PSS resulted in 
a right-ward shift and attenuated maximal contractions. Values are means ± SEM 
 
In aortic rings, the magnitude of enhancement of 
contractions was in the order: HIST > 5-HT > PE 
whereas the order of attenuation by 4.8mM Mg2+ was:  
PE > 5-HT > HIST. 
Figs 2 and 3 show the enhancement and attenuation 
(respectively), of contractile responses to agonists (PE, 
HIST, & 5-HT) in rabbit carotid artery (n = 8), and 
femoral artery (n=8) rings following exposure to Mg2+-
free or high Mg2+ PSS.  
The EC50 values for contractile responses by the three 
agonists and the differential potentiation/attenuation by 
Mg2+-free/high- Mg2+ exposure in aortic, carotid and 
femoral arteries are shown in Tables 1-3.  
The EC50 (M) and EMAX (%) values for agonist-
induced contractile responses and the influence of 
varied (Mg2+)o show that the enhancement by 
(Mg2+)o was in the order - for PE: Femoral artery> 
aorta>carotid artery; for  HIST: Femoral artery> 
carotid>aorta and for 5-HT: Aorta> 
femoral>carotid artery; whereas attenuation by 
high-Mg2+ PSS the order - for PE and HIST: 
Femoral artery>aorta>carotid artery; and for  5-
HT: Carotid artery> aorta>femoral artery 
 
Table 1. EC50 [M] & EMAX (%) values for Phenylephrine contractions 
 
Values are means ± SEM; n =8. 
 
Table 2. EC50 [M] & EMAX (%) values for Histamine contractions 
 
Values are means ± SEM; n =8. 
 
Table 3. EC50 [M] & EMAX (%) values for 5-HTcontractions 
 
Values are means ± SEM; n =8. 
 
DISCUSSION 
The results of the present study are in line with 
previous reports ( Altura and Altura, 1990; Eun et al., 
2004; Goytain and Quamme,2008) that withdrawal of 
(Mg2+)o enhances, while elevation in (Mg2+)o depresses 
contractile responses of vascular smooth muscles. We 
have examined contractile responses induced by three 
agonists and their modulation by altered (Mg2+)o 
vascular reactivity to vasoconstrictor agents: 
phenylephrine, histamine and 5-HT, as well as 
modification of their responses following exposure to 
varying (Mg2+)o, in a variety of blood vessels. Based on 
[Mg2+]o and agonist-induced contractions 
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the EC50 values for the 3 agonists studied, it is clear that 
a considerable heterogeneity exists in the contractile 
responses induced by the agonists following exposure 
to varied (Mg2+)o media. A number of studies have 
shown that regional and species variations exist in the 
responses of isolated arteries to a variety of vasoactive 
agents (Toda and Miyazaki, 1978; Toda et al, 1990; 
Daemen and De Mey, 1995). Most of the previously 
reported studies have focused on blood vessels obtained 
from the rabbit, dog, or monkey and have not 
examined, comparatively, the modulation by (Mg2+)o  
of contractile responses to agonists  in vascular smooth 
muscle from different regional sites in the same animal 
species.  
The agonists examined in this study elicit vascular 
smooth muscle contraction by mobilizing intracellular 
calcium pools as well as stimulating Ca2+ influx 
through receptor-operated channels (Bolton, 1979; 
Ebeigbe, 1982). Therefore, the observations and 
findings from our data could be interpreted to indicate 
that Mg2+ might interfere with the binding of these 
agonists to their various receptors in rabbit arterial 
blood vessels as has been reported by other workers 
(Altura and Turlapaty, 1982). A variety of mechanisms 
may account for the differential modulation by (Mg2+)o 
of agonist-induced contractions of arterial preparations: 
previous studies indicate that magnesium ion can either 
increase or decrease the affinity of various agonists for 
their specific receptors in different types of vascular 
smooth muscle (Somlyo et al., 1966; Altura and Altura, 
1971., Goldstein and Zsoter, 1978). Furthermore, 
differences in responsiveness of these agonists and 
modulation by Mg2+ of  contractile responses in arteries 
from different regional sites may result from 
differences in the properties of regulation of the 
contractile processes (Eun et al., 2004; D'Angelo et al., 
1992), properties of vascular agonists  specific 
receptors and /or diversity of smooth muscle types; as 
well as up or down regulation of vascular smooth 
muscle population density in the length and regional 
vascular beds (Miwa and Toda,1994, Bascands et al., 
2001). Also, (Mg2+)o impairs Ca2+ influx into vascular 
smooth muscle cells and also acts intracellularly as 
Ca2+ antagonist (Turlapaty et al 1981; Altura and 
Altura, 1983), thereby modulating the vasoconstrictor 
action of (Ca2+)i, a major determinant of vascular 
smooth muscle contraction (Zheng et al, 2011).  
 
CONCLUSION 
In conclusion, vascular smooth muscle of rabbit aorta, 
carotid and femoral arteries exhibit considerable 
heterogeneity in their contractile responses to different 
agonists and modulation by extracellular magnesium 
concentration. Although the precise mechanisms for the 
differential effects reported are not clear, an 
understanding of vascular reactivity pattern across 
regional beds is of vital importance for regional blood 
flow regulation and cardiovascular function.  
 
REFERENCES 
Altura B.M., Altura B.T. (1971). Influence of 
magnesium on drug-induced                        
contractions and ion content in rabbit aorta.  Am. J. 
Physiol., 220:938-944. 
Altura B.M.,  Altura, BT.(1978a). Magnesium and 
vascular tone and reactivity.  Blood Vessels. 15: 5-16  
Altura  B.M.,  Altura B.T. (1981a). Magnesium ions 
and the contraction of vascular smooth  muscles:  
Relationship to some vascular diseases.  Fed. Proc. 
Fed. Am. Soc. Exp. Biol. 2672-2679 
Altura B.M., Altura B.T. (1990). Magnesium and the 
cardiovascular system: experimental and clinical 
aspects updated. In metal ions in biological system. 
26:  Compendium on magnesium and its role in 
biological, nutrition and physiology. Ed. Sigel H. pp 
359-416, New York: Marcel Dekker Inc. 
Altura B.M., Turlapaty P.D.M.V. (1982). Withdrawal 
of magnesium enhances coronary arterial spasms 
produced by vasoactive agents. Br. J. Pharmac, 77: 
649-659 
Bascands  J., Girolami J., Muriel T.,  Escargueil-Blanc 
I., Dani N., Robert S., Nelly B.  (2001). Angiotensin 
11 induces phenotype-development apoptosis in 
vascular smooth muscle cells.  
Hypertension.38:1294-1299  
Bolton T.B. (1979) Mechanisms of action of 
transmitters and other substances on smooth muscle. 
Physiological review: 59 (3): 607-718.  
Daemen Mat J.A.P.,  De Mey Jo G.R. (1995). Regional 
Heterogeneity of Arterial Structural Changes. 
Hypertension. 2:464-473.)  
D' Angelo E.K., Singer  H.A., Rembold C.M., (1992). 
Mg2+ relaxes arterial smooth muscle by                           
decreasing intracellular  Ca2+ without changing 
intracellular Mg2+. J Clin Invest. 89: 1988-2994. 
Ebeigbe AB and Aloamaka CP, (1986).Extracellular 
magnesium and contractile responses to                               
noradrenaline in the rat tail arteries. Comp. 
Physiol. 83 (1):123-6 
Ebeigbe AB and Aloamaka CP, (1987). Role of 
endothelium in magnesium-induced relaxation of rat 
aorta. Res, Exp,Med. 187: 25-31 
Ebeigbe AB,(1982). Calcium pools for noradrenaline 
and potassium-induced contraction of rat portal vein. 
Canadian J. Physiol.Pharmacol, 60:1225-1227.  
Eun A., Won K, Son P, Yung EA, (2004.) Extracellular 
Mg2+ blocks endothelin-1-induced  contraction 
through the inhibition of non-selective cation 
channels in coronary  smooth muscle Arch. Eur. J 
Physiol 449: 195–204 
Gold  ME,  Buga  GM, Wood KS, Byrns RE, (1990). 
Antagonistic modulatory roles of  magnesium and 
[Mg2+]o and agonist-induced contractions 
83                                   J. Afr. Ass. Physiol. Sci. 3 (2): December, 2015                                    Uche and Ebeigbe                              
 
calcium on release of endothelium-derived relaxing 
factor and smooth muscle tone. Circulation 
Research. 66: 355-366. 
Goldstein, S.,  Zsotpr, T.T. (1978). The effect of 
magnesium on the response of smooth muscle to 5-
hydroxytryptamine. Br. J. Pharmacol., 62,507-514. 
Goytain A., Quamme G.A. (2008) Identification and 
characterization of a novel family of                            
membrane magnesium transporters, MMgT1 and 
MMgT2. Am J Physiol Cell Physiol 294: C495-C502  
He Y., Guoying Y., Carmine S., Rhian M., Touyz 
(2005). Transient Receptor Potential       melastatin 7 
Ion Channels Regulate Magnesium Homeostasis in 
vascular Smooth Muscle Cells. Role of Angiotensin 
11. Circ Res. 96: 207-215  
Miwa  K., Toda, N. (1984). Regional differences in the 
responses to vasoconstrictor agents of                                    
dog and monkey isolated coronary arteries. Br. J. 
Pharmacol.82: 295-301  
Obiefuna  P.C.M., Sofola O.A., Ebeigbe A.B. (1991). 
Depressed magnesium-induced                          
relaxation in aortic rings from salt loaded rats. 
Nig.J.Physiol. Sci.7(1): 59-62 
Pascal L., Rhian M.T., Ernesto L.S. (1997).Effect of 
magnesium on vascular tone and                               
reactivity in pressurized mesenteric resistance 
arteries from spontaneously hypertensive  rats. Can. 
J. Physiol. Pharmacol. 75: 293-300 
Saris  N.L.,  Eero M., Heikki K.,  Jahangir A.,  
Khawaja  A.L., (2000). Magnesium: An update                     
on physiological, clinical and analytical aspects. 
Clinica Chimica Acta 294: 1–26. 
Somlyo A.V., Woo Cy., & Somlyo, A.P. (1966). Effect 
of magnesium on posterior pituitary hormone action 
of vascular smooth muscle. Am. J. Physiol., 210,705 
-714. 
Sontia B. Touyz .R.M., (2006). Role of magnesium in 
hypertension.  Arch. Biophysics.30: 1-7 
Turlapty P.D.M.V., Weiner  R.,  Altura  B.M., (1981). 
Interactions of magnesium and verapamil on tone and 
contractility of vascular smooth muscle. Eur. J. 
Pharmacol 74: 263-272. 
Toda N, Ayaziki K, Okamura T, (1990).Modifications 
by endogenous prostaglandins of                                
angiotensin 11-induced contractions in dog and 
monkey cerebral and mesenteric arteries. J 
Pharmacol Exp Ther. 252(1) 374-9 
Toda N., Miyazaki M.. (1978). Regional and species 
differences in the response of isolatedarteries to 
angiotensin 11. Jpn J Pharmacol. 28: 495-497 
Touyz R.M., (2008). Transient receptor potential 
melastatin 6 and 7 channels, magnesium                                 
transport, and vascular biology: implications in 
hypertension.  Am J Physiol heart Circ Physiol 294: 
H1103-H1118. 
Zheng T, Wenyan  L, Altura BT, Shah NC and Altura 
BM (2011). Sphingolipids regulate [Mg2+]o uptake 
and [Mg2+]i content in vascular smooth muscle cells:  
potential mechanisms and importance to membrane 
transport of Mg2+ .  Am. J Physiol Heart Cir Physiol 
300: H486-H492.  
 
